These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15543328)

  • 1. Warfarin prophylaxis and venous thromboembolism in the first 5 days following hip and knee arthroplasty.
    Brotman DJ; Jaffer AK; Hurbanek JG; Morra N
    Thromb Haemost; 2004 Nov; 92(5):1012-7. PubMed ID: 15543328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
    Enyart JJ; Jones RJ
    Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal hormone replacement and venous thromboembolism following hip and knee arthroplasty.
    Hurbanek JG; Jaffer AK; Morra N; Karafa M; Brotman DJ
    Thromb Haemost; 2004 Aug; 92(2):337-43. PubMed ID: 15269830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of anesthesia and venous thromboembolism after hip and knee arthroplasty.
    Jaffer AK; Barsoum WK; Krebs V; Hurbanek JG; Morra N; Brotman DJ
    Mayo Clin Proc; 2005 Jun; 80(6):732-8. PubMed ID: 15945526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin Alone Is Not Enough to Prevent Deep Venous Thrombosis After Total Joint Arthroplasty.
    Woon CYL; Shah RR; Pardi BM; Schwartz BE; Goldstein JM; Cipparrone NE; Goldstein WM
    Orthopedics; 2019 Jan; 42(1):48-55. PubMed ID: 30602046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of post-discharge venous thromboembolism on hospital quality comparisons following hip and knee arthroplasty.
    Kester BS; Merkow RP; Ju MH; Peabody TD; Bentrem DJ; Ko CY; Bilimoria KY
    J Bone Joint Surg Am; 2014 Sep; 96(17):1476-84. PubMed ID: 25187587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Venous thromboembolism prophylaxis after total hip arthroplasty].
    Kučera T; Malý R; Urban K; Sponer P
    Acta Chir Orthop Traumatol Cech; 2011; 78(2):101-5. PubMed ID: 21575551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.
    Comp PC; Spiro TE; Friedman RJ; Whitsett TL; Johnson GJ; Gardiner GA; Landon GC; Jové M;
    J Bone Joint Surg Am; 2001 Mar; 83(3):336-45. PubMed ID: 11263636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dabigatran: new drug. Continue to use heparin, a better-known option.
    Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism rates in patients undergoing major hip and knee joint surgery at Waitemata District Health Board: a retrospective audit.
    Dixon J; Ahn E; Zhou L; Lim R; Simpson D; Merriman EG
    Intern Med J; 2015 Apr; 45(4):416-22. PubMed ID: 25644232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mark Coventry Award: Prevention of readmission for venous thromboembolism after total knee arthroplasty.
    Pellegrini VD; Donaldson CT; Farber DC; Lehman EB; Evarts CM
    Clin Orthop Relat Res; 2006 Nov; 452():21-7. PubMed ID: 16906107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.
    Friedman RJ; Dahl OE; Rosencher N; Caprini JA; Kurth AA; Francis CW; Clemens A; Hantel S; Schnee JM; Eriksson BI;
    Thromb Res; 2010 Sep; 126(3):175-82. PubMed ID: 20434759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux.
    Turpie AG
    Surg Technol Int; 2004; 13():261-7. PubMed ID: 15744699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
    Bawa H; Weick JW; Dirschl DR; Luu HH
    J Am Acad Orthop Surg; 2018 Oct; 26(19):698-705. PubMed ID: 30153117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
    Dager WE
    Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
    Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
    Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.